Procter & Gamble Hygiene & Health Care Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 4.13% vs -18.52% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -46.10% vs -74.26% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P&G Hygiene With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

937.67

119.96

817.71

681.65%

Other Operating Income

3.65

12.08

-8.43

-69.78%

Total Operating income

941.32

132.04

809.28

612.91%

Raw Material Cost

170.68

52.93

117.75

222.46%

Purchase of Finished goods

193.24

20.45

172.79

844.94%

(Increase) / Decrease In Stocks

-7.11

-18.72

11.61

62.02%

Employee Cost

56.53

8.81

47.72

541.66%

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

-0.01

-100.00%

Selling and Distribution Expenses

132.54

0.00

132.54

Other Expenses

177.13

18.97

158.16

833.74%

Total Expenditure (Excl Depreciation)

723.01

82.45

640.56

776.91%

Operating Profit (PBDIT) excl Other Income

218.31

49.59

168.72

340.23%

Other Income

12.47

0.00

12.47

Operating Profit (PBDIT)

230.78

49.59

181.19

365.38%

Interest

3.11

0.87

2.24

257.47%

Exceptional Items

0.00

Gross Profit (PBDT)

227.67

48.72

178.95

367.30%

Depreciation

9.56

1.27

8.29

652.76%

Profit Before Tax

218.11

47.45

170.66

359.66%

Tax

64.98

11.19

53.79

480.70%

Provisions and contingencies

0.00

Profit After Tax

153.13

36.26

116.87

322.31%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

153.13

36.26

116.87

322.31%

Equity Capital

32.46

134.47

-102.01

-75.86%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

47.17

0.27

46.90

17,370.37%

Diluted Earnings per share

47.17

0.27

46.90

17,370.37%

Operating Profit Margin (Excl OI)

23.28%

41.34%

0.00

-18.06%

Gross Profit Margin

24.28%

40.61%

0.00

-16.33%

PAT Margin

16.33%

30.23%

0.00

-13.90%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 937.67 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -25.58% vs 9.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 153.13 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -49.20% vs 43.65% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 218.31 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -45.67% vs 41.10% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 4.13% vs -18.52% in Mar 2025

Quarterly - Interest

Interest 3.11 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 16.48% vs -25.83% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -46.10% vs -74.26% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 23.28%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025